These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 18771410

  • 1. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
    Hájek Z, Germanová A, Koucký M, Zima T, Kopecký P, Vítkova M, Parízek A, Kalousová M.
    J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
    [Abstract] [Full Text] [Related]

  • 2. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
    Germanová A, Koucký M, Hájek Z, Parízek A, Zima T, Kalousová M.
    Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
    [Abstract] [Full Text] [Related]

  • 3. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH.
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [Abstract] [Full Text] [Related]

  • 4. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A.
    Arthritis Res Ther; 2005 Feb; 7(4):R817-24. PubMed ID: 15987483
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
    Tesarová P, Kalousová M, Jáchymová M, Mestek O, Petruzelka L, Zima T.
    Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [Abstract] [Full Text] [Related]

  • 9. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K, Somoza V, Jarcusková M, Heidland A, Podracká L.
    Int J Pediatr Obes; 2009 May; 4(2):112-8. PubMed ID: 18645732
    [Abstract] [Full Text] [Related]

  • 10. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S, Adachi H, Nakamura K, Matsui T, Jinnouchi Y, Takenaka K, Takeuchi M, Enomoto M, Furuki K, Hino A, Shigeto Y, Imaizumi T.
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [Abstract] [Full Text] [Related]

  • 11. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
    Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL.
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):129-34. PubMed ID: 18595673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The soluble receptor for advanced glycation end products can prospectively identify patients at greatest risk for preterm birth.
    Bastek JA, Brown AG, Foreman MN, McShea MA, Anglim LM, Adamczak JE, Elovitz MA.
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1762-8. PubMed ID: 22339587
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes.
    Malícková K, Kalousová M, Fucíková T, Bortlík M, Duricová D, Komárek V, Zima T, Janatková I, Lukás M.
    Scand J Clin Lab Invest; 2010 Jul; 70(4):294-9. PubMed ID: 20446880
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
    Sternberg Z, Weinstock-Guttman B, Hojnacki D, Zamboni P, Zivadinov R, Chadha K, Lieberman A, Kazim L, Drake A, Rocco P, Grazioli E, Munschauer F.
    Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
    Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M, Geroldi D.
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
    [Abstract] [Full Text] [Related]

  • 20. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes.
    Su XD, Li SS, Tian YQ, Zhang ZY, Zhang GZ, Wang LX.
    Arch Med Res; 2011 Oct; 42(7):596-601. PubMed ID: 22100610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.